
GlucoTrack Investor Relations Material
Latest events

Q2 2025
14 Aug, 2025

Q1 2025
14 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from GlucoTrack Inc
Access all reports
GlucoTrack, Inc. is a medical device company focused on developing and commercializing innovative technologies designed for people with diabetes. The company’s flagship product, also named GlucoTrack, is a non-invasive glucose monitoring device that allows users to obtain blood glucose readings without the need for fingersticks or other invasive procedures. Additionally, GlucoTrack is working on a long-term implantable continuous blood glucose monitor (CBGM) aimed at providing accurate, continuous glucose monitoring for extended periods, addressing challenges such as calibration and comfort found in traditional CGM systems. GlucoTrack, Inc. is headquartered in Rutherford, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
GCTK
Country
🇺🇸 United States